Sol-Gel Technologies (NASDAQ: SLGL) is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Our current product candidate pipeline consists of late-stage branded product candidates that leverage our proprietary silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.
Our unique technology platform was designed to enable drug substances to be entrapped in porous silica microcapsules in order to address the limitations of topical drug delivery by stabilizing active drug ingredients, extending drug delivery time and reducing potential irritation caused by direct application to the skin.
For more information, please visit www.Sol-Gel.com
Company Details
- Employees
- 47
- Address
- 7 Golda Meir St., Ness Ziona,israel
- Phone
- 972 8 931 3433
- mo****@****ngs.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.sol-gel.com
- Keywords
- Engineer jobs.
- HQ
- Ness Ziona
Sol-Gel Questions
Sol-Gel's helpline number is 972 8 931 3433
Sol-Gel's website is https://www.sol-gel.com
Sol-Gel's LinkedIn profile is https://www.linkedin.com/company/sol-gel-technologies
Sol-Gel has
47 employees.
View email and phone details for 47
employees at Sol-Gel.
Sol-Gel's industry is
Biotechnology Research
Sol-Gel's top competitors are
Mileutis Ltd.,
Foamix Pharmaceuticals,
Mediwound,
Kamada,
Tytocare,
500tech,
Chiral Energy,
Galderma,
Evogene,
Mapi Pharma.
Sol-Gel's support email address is mori@arkinholdings.com
Sol-Gel's categories are Biotechnology Research
